At the 2026 MDA Conference in Orlando, Genethon unveiled new two‑year efficacy data for its gene therapy candidate GNT0004, a key milestone for Duchenne muscular dystrophy research.
Background Patients with single ventricles after bidirectional Glenn (BDG) are placed on ACE inhibitors (ACEIs) to reduce afterload and to decrease systemic to pulmonary collateral flow (SPC). The ...
Morning Overview on MSN
Brain glitch may finally reveal why Alzheimer’s risk soars with age
Researchers have identified a specific type of neural malfunction in the hippocampus that may explain why Alzheimer’s disease risk climbs so sharply after age 75. The problem centers on overactive ...
A growing body of neuroscience research is challenging the long-held assumption that general anesthesia works by simply switching the brain off. Instead, multiple independent studies now point to a ...
Tech Xplore on MSN
Holographic storage approach packs more data into the same space by encoding three properties of light
Researchers have developed a holographic data storage approach that stores and retrieves information in three dimensions by ...
AI-enhanced single-shot cine MRI produces superior image quality and provides ventricular measurements comparable to conventional cine MRI, according to research published in Radiology: Cardiothoracic ...
Sports cardiology has emerged as a distinct subspecialty at the intersection of preventive cardiology and athlete care. While ...
Rachel works as a CRNA where she provides anesthesia care across the lifespan, including pediatric anesthesia, with a primary focus on orthopedic anesthesia. She is also an Assistant Professor at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results